Course Content
01. Angina Pectoris: The Core Clinical Problem
You don't currently have access to this content
02. Myocardial Oxygen Demand: MVOâ‚‚
You don't currently have access to this content
03. Myocardial Oxygen Supply
You don't currently have access to this content
04. Clinical Phenotypes of Angina
You don't currently have access to this content
05. Antianginal Pharmacology: Big Picture
You don't currently have access to this content
06. Organic Nitrates I: Mechanism of Action
You don't currently have access to this content
07. Organic Nitrates II: Hemodynamics and Clinical Use
You don't currently have access to this content
08. Organic Nitrates III: Toxicity, Tolerance, and Interactions
You don't currently have access to this content
09. Beta Blockers I: Mechanism in Angina
You don't currently have access to this content
10. Beta Blockers II: Clinical Use and Pitfalls
You don't currently have access to this content
11. Calcium Channel Blockers I: Class Logic
You don't currently have access to this content
12. Calcium Channel Blockers II: Clinical Use and Toxicity
You don't currently have access to this content
13. Ranolazine: Late Sodium Current Inhibitor
You don't currently have access to this content
14. Ivabradine, Nicorandil, and Trimetazidine
You don't currently have access to this content
15. Coronary Steal Phenomenon
You don't currently have access to this content
16. Vasospastic Angina: Targeted Treatment
You don't currently have access to this content
17. Microvascular Angina and INOCA
You don't currently have access to this content
18. Rational Combination Therapy
You don't currently have access to this content
19. Disease-Modifying Therapy in Coronary Disease
You don't currently have access to this content
20. Acute Coronary Syndromes: Modern Pharmacologic Frame
You don't currently have access to this content
21. Comparative Antianginal Matrix
You don't currently have access to this content
22. High-Yield Clinical Reasoning Cases
You don't currently have access to this content
23. Board-Style Final Takeaways
You don't currently have access to this content

